Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Zambelli

Showing results (81-90 of 162) with videos related to

Pageof 17
Sort By:
Critical Reviews in Oncology/Hematology|February 7, 2026
Real-World Evidence for 10 Oncology Drugs Approved in the last 5 years: A Comprehensive Narrative SynthesisFausto Petrelli, Lara Colombo Zefinetti, Maria Chiara Parati, et al.
Calcified Tissue International|July 28, 2022
Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase InhibitorsGherardo Mazziotti, Rebecca Pedersini, Walter Vena, et al.
Journal of Medical Internet Research|January 26, 2022
A Remote Monitoring System to Optimize the Home Management of Oral Anticancer Therapies (ONCO-TreC): Prospective Training-Validation TrialAlessandro Passardi, Flavia Foca, Orazio Caffo, et al.
Oncology and Therapy|May 1, 2025
Bone Metastases and Skeletal Complications: Information and Involvement of Patients with Cancer in the Treatment PathwayStefania Gori, Alessandra Fabi, Giuseppe Procopio, et al.
Immunology|April 26, 2002
T-cell dynamics after high-dose chemotherapy in adults: elucidation of the elusive CD8+ subset reveals multiple homeostatic T-cell compartments with distinct implications for immune competenceFrancesco F Fagnoni, Laura Lozza, Carlo Zibera, et al.
Breast (Edinburgh, Scotland)|April 24, 2020
Prospective observational study on the impact of the 21-gene assay on treatment decisions and resources optimization in breast cancer patients in Lombardy: The BONDX studyAlberto Zambelli, Edda Simoncini, Monica Giordano, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Development and Preliminary Validation of a Tool to Assess Barriers and Facilitators to Participation in Adjuvant Endocrine Therapy Switch TrialsSilvia Belloni, Paola Tiberio, Emanuela Mencaglia, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2026
Comprehensive review of pregnancy associated breast cancer: Clinical features, molecular characteristics and novel therapiesAlessandra Spata, Joana M Ribeiro, Paolo Vigneri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Pilot study of the mechanism of action of preoperative trastuzumab in patients with primary operable breast tumors overexpressing HER2Roberto Gennari, Sylvie Menard, Francesco Fagnoni, et al.
The Oncologist|June 12, 2025
Pre-existing and emerging immune-mediated diseases in patients with breast cancer undergoing cyclin-dependent kinases 4/6 inhibitors and endocrine therapyFlavia Jacobs, Mariangela Gaudio, Chiara Andreottola, et al.
Pageof 17

Showing results (81-90 of 162) with videos related to

Sort By:
Pageof 17
Critical Reviews in Oncology/Hematology|February 7, 2026
Real-World Evidence for 10 Oncology Drugs Approved in the last 5 years: A Comprehensive Narrative SynthesisFausto Petrelli, Lara Colombo Zefinetti, Maria Chiara Parati, et al.
Calcified Tissue International|July 28, 2022
Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase InhibitorsGherardo Mazziotti, Rebecca Pedersini, Walter Vena, et al.
Journal of Medical Internet Research|January 26, 2022
A Remote Monitoring System to Optimize the Home Management of Oral Anticancer Therapies (ONCO-TreC): Prospective Training-Validation TrialAlessandro Passardi, Flavia Foca, Orazio Caffo, et al.
Oncology and Therapy|May 1, 2025
Bone Metastases and Skeletal Complications: Information and Involvement of Patients with Cancer in the Treatment PathwayStefania Gori, Alessandra Fabi, Giuseppe Procopio, et al.
Immunology|April 26, 2002
T-cell dynamics after high-dose chemotherapy in adults: elucidation of the elusive CD8+ subset reveals multiple homeostatic T-cell compartments with distinct implications for immune competenceFrancesco F Fagnoni, Laura Lozza, Carlo Zibera, et al.
Breast (Edinburgh, Scotland)|April 24, 2020
Prospective observational study on the impact of the 21-gene assay on treatment decisions and resources optimization in breast cancer patients in Lombardy: The BONDX studyAlberto Zambelli, Edda Simoncini, Monica Giordano, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Development and Preliminary Validation of a Tool to Assess Barriers and Facilitators to Participation in Adjuvant Endocrine Therapy Switch TrialsSilvia Belloni, Paola Tiberio, Emanuela Mencaglia, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2026
Comprehensive review of pregnancy associated breast cancer: Clinical features, molecular characteristics and novel therapiesAlessandra Spata, Joana M Ribeiro, Paolo Vigneri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Pilot study of the mechanism of action of preoperative trastuzumab in patients with primary operable breast tumors overexpressing HER2Roberto Gennari, Sylvie Menard, Francesco Fagnoni, et al.
The Oncologist|June 12, 2025
Pre-existing and emerging immune-mediated diseases in patients with breast cancer undergoing cyclin-dependent kinases 4/6 inhibitors and endocrine therapyFlavia Jacobs, Mariangela Gaudio, Chiara Andreottola, et al.
Pageof 17